Market open
Clarivate/$CLVT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Clarivate
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.
Ticker
$CLVT
Sector
Trading on
NYSE
Industry
Professional Services
Headquarters
Employees
12,000
Website
Clarivate Metrics
BasicAdvanced
$3.1B
-
-$0.96
1.17
-
Price and volume
Market cap
$3.1B
Beta
1.17
52-week high
$8.24
52-week low
$4.22
Average daily volume
6.2M
Financial strength
Current ratio
0.868
Quick ratio
0.755
Long term debt to equity
88.965
Total debt to equity
89.391
Interest coverage (TTM)
0.83%
Management effectiveness
Return on assets (TTM)
1.21%
Return on equity (TTM)
-11.44%
Valuation
Price to revenue (TTM)
1.234
Price to book
0.61
Price to tangible book (TTM)
-0.65
Price to free cash flow (TTM)
9.868
Growth
Revenue change (TTM)
-2.74%
Earnings per share change (TTM)
-34.48%
3-year revenue growth (CAGR)
10.85%
3-year earnings per share growth (CAGR)
16.20%
What the Analysts think about Clarivate
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Clarivate stock.
Clarivate Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Clarivate Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Clarivate News
AllArticlesVideos
Clarivate Plc (CLVT) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 week ago
Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034
GlobeNewsWire·1 month ago
Bargains Galore? 3 Stocks With Insider Buying in the Millions
MarketBeat·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Clarivate stock?
Clarivate (CLVT) has a market cap of $3.1B as of February 27, 2025.
What is the P/E ratio for Clarivate stock?
The price to earnings (P/E) ratio for Clarivate (CLVT) stock is 0 as of February 27, 2025.
Does Clarivate stock pay dividends?
No, Clarivate (CLVT) stock does not pay dividends to its shareholders as of February 27, 2025.
When is the next Clarivate dividend payment date?
Clarivate (CLVT) stock does not pay dividends to its shareholders.
What is the beta indicator for Clarivate?
Clarivate (CLVT) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.